ARCHIVES

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Medicare Should Pay Routine Care For Patients in Trials: IOM.

January 7, 2000

In Brief: Henry Kaplan Dies Of Lung Cancer At 65; LED Development Of Hodgkin’s Disease Treatment

February 10, 1984

Older Patients Can Do Well With Stem Cell Transplants

March 30, 2007

In Brief: Lasagna Committee Report Finalized; Robinson Replaces Schmidt On MSK Boards

July 13, 1990

Two Workshops To Look For New Research Areas

October 29, 1976

NCI-supported meeting included tobacco industry representatives in dialogue on ethics.

October 29, 2004